Haematologica (Sep 2024)
Adverse prognostic impact of <i>KIT</i> exon 17 mutations despite negative flow cytometric measurable residual disease in pediatric acute myeloid leukemia with <i>RUNX1::RUNX1T1</i>
- Shota Kato,
- Shin-Ichi Tsujimoto,
- Jun Matsubayashi,
- Shotaro Iwamoto,
- Hidefumi Hiramatsu,
- Yusuke Okuno,
- Tatsuya Kamitori,
- Kentaro Ohki,
- Takao Deguchi,
- Nobutaka Kiyokawa,
- Motohiro Kato,
- Junko Takita,
- Shiro Tanaka,
- Souichi Adachi,
- Daisuke Tomizawa,
- Norio Shiba
Affiliations
- Shota Kato
- Department of Pediatrics, Graduate School of Medicine, the University of Tokyo, Tokyo
- Shin-Ichi Tsujimoto
- Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama
- Jun Matsubayashi
- Center for Clinical Research and Advanced Medicine, Shiga University of Medical Science, Otsu
- Shotaro Iwamoto
- Department of Pediatrics, Graduate School of Medicine Mie University, Tsu
- Hidefumi Hiramatsu
- Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto
- Yusuke Okuno
- Department of Virology, Nagoya City University Graduate School of Medical Sciences, Nagoya
- Tatsuya Kamitori
- Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto
- Kentaro Ohki
- Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo
- Takao Deguchi
- Division of Cancer Immunodiagnostics, Children’s Cancer Center, National Center for Child Health and Development, Tokyo
- Nobutaka Kiyokawa
- Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo
- Motohiro Kato
- Department of Pediatrics, Graduate School of Medicine, the University of Tokyo, Tokyo
- Junko Takita
- Department of Pediatrics, Graduate School of Medicine Kyoto University, Kyoto
- Shiro Tanaka
- Department of Clinical Biostatistics, Graduate School of Medicine, Kyoto University, Kyoto
- Souichi Adachi
- Human Health Science, Graduate School of Medicine Kyoto University, Kyoto, Japan; and
- Daisuke Tomizawa
- Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo
- Norio Shiba
- Department of Pediatrics, Yokohama City University Graduate School of Medicine, Yokohama
- DOI
- https://doi.org/10.3324/haematol.2024.286243
- Journal volume & issue
-
Vol. 999,
no. 1
Abstract
Not available.
